Shree Ganesh Bio-Tech Intrinsic Value
Shree Ganesh Bio-Tech (SHREEGANES) median intrinsic value is ₹1.18 from 7 valuation models (range ₹0–₹2), vs current price ₹0.59 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Also explore Shree Ganesh Bio-Tech stock price data download to track price trends across different timeframes.
SHREEGANES Valuation Methods Summary — DCF, Graham Number & P/E
Shree Ganesh Bio-Tech intrinsic value across 7 models vs current price ₹0.59 — upside/downside and value range per method. Browse SHREEGANES cash flow statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹0.22 | ₹0.18 - ₹0.26 | -62.7% | EPS: ₹0.01, Sector P/E: 22x |
| Book Value Method | asset | ₹1.47 | ₹1.32 - ₹1.62 | +149.2% | Book Value/Share: ₹16.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1.18 | ₹1.06 - ₹1.30 | +100.0% | Revenue/Share: ₹1.25, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹1.47 | ₹1.18 - ₹1.76 | +149.2% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹0.18 | ₹0.16 - ₹0.20 | -69.5% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹0.18 | ₹0.16 - ₹0.20 | -69.5% | Revenue Growth: -30.0%, Adj P/E: 12.8x |
| Graham Defensive Method | conservative | ₹1.77 | ₹1.59 - ₹1.95 | +200.0% | EPS: ₹0.01, BVPS: ₹16.00 |
SHREEGANES Intrinsic Value vs Market Price — All Valuation Models
Shree Ganesh Bio-Tech fair value range ₹0–₹2 vs current market price ₹0.59 across 7 valuation models. For current market price and key ratios, visit SHREEGANES share price.
SHREEGANES Intrinsic Value Analysis — Undervalued or Overvalued?
Shree Ganesh Bio-Tech median intrinsic value ₹1.18, current price ₹0.59 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of SHREEGANES?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Shree Ganesh Bio-Tech (SHREEGANES) is ₹1.18 (median value). With the current market price of ₹0.59, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹0.18 to ₹1.77, indicating ₹0.18 - ₹1.77.
Is SHREEGANES undervalued or overvalued?
Based on our multi-method analysis, Shree Ganesh Bio-Tech (SHREEGANES) appears to be trading below calculated value by approximately 100.0%.
SHREEGANES Financial Health — Key Ratios vs Industry Benchmarks
Shree Ganesh Bio-Tech financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | -19.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.08x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
SHREEGANES Cash Flow Quality — Operating & Free Cash Flow
Shree Ganesh Bio-Tech operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-10 Cr | ₹-10 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹10 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹11 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |